Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

6051–6075 of 11856

SevereFDA (Drugs)·D-0981-2018·2018-08-01
Teva Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity
Teva Pharmaceuticals USA is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 80 mg/12.5 mg tablets, 90 count-count bottle, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, NDC 0591-2315-19.
Category
Drug
Distribution
2 states
SevereFDA (Drugs)·D-0966-2018·2018-08-01
Major Pharmaceuticals Recalls Valsartan Tablets Due to Carcinogen Impurity
Major Pharmaceuticals is recalling specific lots of 80 mg Valsartan tablets because a carcinogen impurity was detected in the active ingredient.
Product
Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by: Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0987-2018·2018-08-01
Teva Recalls Valsartan Tablets Due to Carcinogen Impurity
Teva Pharmaceuticals USA is recalling specific lots of Valsartan Tablets 80 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets, USP 80 mg, 90-count bottle (NDC 0591-2168-19), 1000-count bottle (NDC 0591-2168-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054
Category
Drug
Distribution
2 states
SevereFDA (Drugs)·D-0971-2018·2018-08-01
Prinston Recalls Valsartan Tablets Due to Carcinogen Impurity
Prinston Pharmaceutical Inc. is recalling Valsartan tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
VALSARTAN — VALSARTAN (VALSARTAN)
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-0973-2018·2018-08-01
Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity
Prinston Pharmaceutical Inc. is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-0976-2018·2018-08-01
Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity
Prinston Pharmaceutical Inc is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-0988-2018·2018-08-01
Teva Recalls Valsartan Tablets Due to Carcinogen Impurity in API
Teva Pharmaceuticals USA is recalling specific lots of Valsartan Tablets 160 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054
Category
Drug
Distribution
2 states
HighFDA (Drugs)·D-0977-2018·2018-08-01
Sun Pharmaceutical Recalls Testosterone Cypionate Injection Due to Particulate Matter
Sun Pharmaceutical Industries is recalling Testosterone Cypionate Injection vials because organic and inorganic particulate matter was detected in the product.
Product
TESTOSTERONE CYPIONATE — TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0962-2018·2018-07-25
Avella Recalls Phenylephrine IV Bags Due to Sterility Concerns
Avella of Deer Valley is recalling 120 bags of Phenylephrine 20 mg IV solution due to potential bag leakage and lack of sterility assurance.
Product
PHENYLephrine 20 mg (PHENYLephrine HCL (USP) 20 mg, 5% Dextrose (USP) 250 mL) Volume: 252 mL. Single dose bag. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-894-25
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0922-2018·2018-07-25
La Vita Compounding Pharmacy Recalls Methyl Folate Injection Due to Sterility Concerns
La Vita Compounding Pharmacy is recalling Methyl Folate CA+ 1mg/ml Injection vials because production methods raised questions about the sterility of the drug product.
Product
Methyl Folate CA+ 1mg/ml Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-0956-2018·2018-07-25
Avella Recalls Midazolam Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 220 bags of Midazolam 0.5mg/mL due to potential bag leakage and lack of assurance of sterility.
Product
Midazolam 0.5mg/mL (Midazolam HCL (USP) 50 mg, 0.9% Sodium Chloride, USP QS 100 mL) Volume: 100 mL. Single dose bag. For: Coral Gables Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-408-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0940-2018·2018-07-25
Avella Recalls Phenylephrine Bags Due to Potential Leakage
Avella of Deer Valley is recalling 200 bags of Phenylephrine 40 mg due to potential leakage that compromises sterility.
Product
PHENYLephrine 40 mg (PHENYLephrine HCL (USP) 40 mg, 5%Dextrose Inj., USP 250 mL) Volume: 254 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-893-25
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0929-2018·2018-07-25
Avella Recalls CeFAZolin Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley, Inc. is recalling 2,500 bags of ceFAZolin 2 gm in NS 100mL due to potential bag leakage that compromises sterility.
Product
ceFAZolin 2 gm in NS 100mL. ceFAZolin Sodium (USP) 2gm, 0.9% Sodium Chloride (USP) 100mL. Volume 110 mL. Single dose bag. Avella of Houston 9265 Kirby Dr., Houston, TX 77054 NDC: 42852-604-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0945-2018·2018-07-25
Avella Recalls Fentanyl Syringes Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 100 fentanyl syringes due to potential bag leakage and lack of sterility assurance.
Product
fentaNYL 5 mcg Citrate, USP 5 mcg in 0.9% Sodium Chloride, USP QS 0.5mL. (10 mcg per mL) 5 mcg in 0.5 mL. Volume: 0.5 mL. Single dose syringe. For Cook Children's Med Ctr. By: Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-210-72
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0921-2018·2018-07-25
La Vita Compounding Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
La Vita Compounding Pharmacy is recalling Methylcobalamin 1mg/mL Injection vials because production methods raised questions about the sterility of the drug product.
Product
Methylcobalamin 1mg/mL Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), packaged in 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-0923-2018·2018-07-25
La Vita Compounding Pharmacy Recalls Glutathione Injection Due to Sterility Concerns
La Vita Compounding Pharmacy is recalling 191 vials of Glutathione 200mg/mL Injection because production methods raised questions about the sterility of the drug product.
Product
Glutathione 200mg/mL Injection w/Pres. (Benzyl Alcohol 1.5% in Sterile Water), 30 mL vial, Rx only, la VITA Compounding Pharmacy, 858.453.2500
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-0936-2018·2018-07-25
Avella Recalls Magnesium Sulfate Bags Due to Sterility Concerns
Avella of Deer Valley is recalling 100 bags of Magnesium Sulfate in Sodium Chloride due to potential bag leakage and lack of sterility assurance.
Product
MAGnesium 4gm in NS 100 mL (MAGnesium SULfate (USP) 4 gm, 0.9% Sodium Chloride (USP) 100 mL). Volume: 108 mL. Single dose bag. For: Gaston Memorial Hospital By: Avella of Houston, 9256 Kirby Dr., Houston, TX 77054. NDC: 42852-905-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0965-2018·2018-07-25
Avella Recalls Phenylephrine Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 40 bags of Phenylephrine 10 mg due to potential leakage that compromises sterility. The product was distributed nationwide.
Product
PHENYLephrine 10 mg (PHENYLephrine HCL (USP) 10mg, 0.9% Sodium Chloride (USP) 250 mL. Volume: 251 mL Single dose bag. For: Redlands Community Hospital Pharmacy. BY: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054 NDC 15082-856-25
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0947-2018·2018-07-25
Avella Recalls Heparin Bags Due to Potential Sterility Issues
Avella of Deer Valley is recalling 900 bags of Heparin 12,500 Units in 5% Dextrose due to potential bag leakage and lack of sterility assurance.
Product
HEPARIN 12,500 Units in 5% Dextrose. (Heparin Sodium, USP 12,500 Units, 5% Dextrose Inj., USP 250 mL) Volume: 252.5 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue Phoenix, AZ 85085. NDC 42852-745-25
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0938-2018·2018-07-25
Avella Recalls Morphine Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley, Inc. is recalling 1,500 bags of Morphine 1 mg/mL due to potential bag leakage and lack of assurance of sterility.
Product
MORphine 1 mg/mL (Morphine Sulfate, USP 100mg, 0.9% Sodium Chloride, USP QS 100 mL). Volume 100 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-241-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0932-2018·2018-07-25
Avella Recalls Epinephrine Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley, Inc. is recalling 700 bags of Epinephrine (USP) 4 mg due to potential leakage that compromises sterility.
Product
EPINEPHrine (USP) 4 mg, 0.9% Sodium Chloride (USP) 250 mL Volume: 254 mL single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-823-25.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0928-2018·2018-07-25
Avella Recalls Ropivacaine Pumps Due to Potential Sterility Compromise
Avella of Deer Valley is recalling 40 Ropivacaine OnQ pumps due to potential bag leakage that compromises sterility.
Product
0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP) QS 550 ml, single dose pump. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77056. NDC: 42852-661-02
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0957-2018·2018-07-25
Avella Recalls Midazolam Syringes Due to Sterility Assurance Concerns
Avella of Deer Valley, Inc. is recalling 110 syringes of Midazolam 1 mg/mL due to a lack of assurance of sterility and potential bag leakage.
Product
Midazolam 1 mg/mL (Midazolam HCL (USP) 55 mg, 0.9% Sodium Chloride, (USP) QS 55 mL) Volume: 55mL. Single dose syringe. Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-401-76
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0931-2018·2018-07-25
Avella Recalls Epinephrine Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 420 bags of Epinephrine 4 mg in 5% Dextrose due to potential leakage that compromises sterility.
Product
EPINEPHrine (USP) 4 mg, 5% Dextrose For Inj. (USP) 250 mL Volume: 254 mL single dose bag. For: Peninsular Regional Medical Center. By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-855-25.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0950-2018·2018-07-25
Avella Recalls Hydromorphone Injection Bags Due to Sterility Concerns
Avella of Deer Valley, Inc. is recalling 660 bags of Hydromorphone injection due to potential leakage that compromises sterility.
Product
HYDROmorphone 0.2mg/mL. (Hydromorphone HCL (USP) 20 mg, 0.9% Sodium Chloride (USP) QS 100 mL) Volume: 100mL. Single dose bag. Advanced Pharma, 9265 Kirby Dr., Houston,077054 TX. NDC 15082-221-10
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

6051–6075 of 11856